Key Metrics
MARKET CAP
$20.20B
P/E RATIO
N/A
BETA
1.34
More volatile
DIV YIELD
N/A
52W HIGH
$55.20
52W LOW
$22.28
VOLATILITY
51.5%
30d annualized
Price Performance
30-DAY PRICE CHART
$45.45 → $51.71+13.77%
30 days agoToday
1-YEAR PERFORMANCE
$30.96 → $51.71+67.0%
MRNA | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Moderna Inc. is currently trading at $51.71, which is 6.3% below its 52-week high. With a beta of 1.34, the stock shows higher sensitivity to market movements.
RSI (14)OVERBOUGHT
30-DAY TRENDBULLISH
VOLUME5.7M(Below avg)
Frequently Asked Questions
Is MRNA a good buy right now?
Moderna Inc. operates in the Healthcare sector. Current risk level is Very High based on 51.5% volatility.
Does MRNA pay dividends?
Moderna Inc. does not currently pay a regular dividend. The company may be reinvesting profits for growth.
How volatile is MRNA?
With 30-day annualized volatility of 51.5% and beta of 1.34,MRNA is classified as Very High risk. Expect larger swings than the broader market during volatile periods.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track MRNA Live
Add Moderna Inc. to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:59 PM